...[[anosmia/ja|嗅覚の喪失]]と関連している；その結果、2009年6月、[[:en:United States Food and Drug Administration|米国食品医薬品局]]（USFDA）は、経鼻亜鉛の使用を中止するよう消費者に警告した。
...は持続時間を減少させる[[mechanism of action/ja|作用機序]]は、鼻の[[inflammation/ja|炎症]]の抑制と、[[nasal mucosa/ja|鼻粘膜]]における[[Rhinovirus/ja#Pathogenesis|ライノウイルス受容体結合]]およびライノウイルスの[[
...
5 KB (141 words) - 15:59, 20 April 2024
...of smell]]; consequently, in June 2009, the [[United States Food and Drug Administration]] (USFDA) warned consumers to stop using intranasal zinc.
...ceptor binding]] and rhinoviral [[Viral replication|replication]] in the [[nasal mucosa]].
...
4 KB (593 words) - 19:58, 18 April 2024
...of smell]]; consequently, in June 2009, the [[United States Food and Drug Administration]] (USFDA) warned consumers to stop using intranasal zinc.
...ceptor binding]] and rhinoviral [[Viral replication|replication]] in the [[nasal mucosa]].
...
4 KB (617 words) - 19:58, 18 April 2024
Depending on the method/route of administration, dosage forms come in several types. These include many kinds of liquid, so
...e such as [[inhalational]], [[Cheek|buccal]], [[sublingual]], [[human nose|nasal]], [[suppository]] or [[parenteral]] instead. Additionally, a specific dosa
...
9 KB (1,270 words) - 14:41, 6 January 2023
...2003, [[Zicam]] faced lawsuits from users who claimed that the product, a nasal gel containing zinc gluconate and several inactive ingredients, negatively
The U.S. [[Food and Drug Administration]] (FDA) considers zinc gluconate to be [[generally recognized as safe]] (GR
...
5 KB (707 words) - 21:59, 20 April 2024
...2003, [[Zicam]] faced lawsuits from users who claimed that the product, a nasal gel containing zinc gluconate and several inactive ingredients, negatively
The U.S. [[Food and Drug Administration]] (FDA) considers zinc gluconate to be [[generally recognized as safe]] (GR
...
5 KB (727 words) - 21:58, 20 April 2024
...cs| volume=27 | issue=6 | pages=427–439 | date=2004 | quote=Following i.v. administration, the terminal half-life is the time required for plasma/blood concentration
|[[Fluoxetine]]||4–6 days (under continuous administration)<ref name="fluoxetine">Fluoxetine {{Drugs.com|monograph|fluoxetine}}. Acces
...
23 KB (3,078 words) - 12:12, 15 November 2023
| routes_of_administration = [[By mouth/ja]], [[intramuscular/ja]], [[nasal spray/ja]]
...cancer/ja|腸がん]]に起因して起こることがある。経口、[[injection into a muscle/ja|筋肉への注射]]、または[[nasal spray/ja|点鼻薬]]として使用される。
...
20 KB (1,053 words) - 10:13, 7 April 2024
...用することが認められている。例えば、「○○は健康な関節を維持するのに役立ちます」というような表現であるが、ラベルには、[[Food and Drug Administration/ja|食品医薬品局]]（FDA）は「その主張を評価していない」こと、また、栄養補助食品製品は「いかなる疾病の診断、治療、治癒、予防」を意図したものでは
...]、[[preservative/ja|保存料]]、[[pharmaceutical drugs/ja|医薬品]]ではないものによって定義される。[[nasal spray/ja|鼻腔スプレー]]として、あるいはローションとして皮膚に塗布する[[Topical medication/ja|局所的]]な使用を目的
...
53 KB (1,344 words) - 20:01, 6 April 2024
...allow it to dissolve under the tongue, also referred to as ''[[sublingual administration]].'' For example, a hard candy can be dissolved under the tongue, however t
...foods to help the hypoglycemic eat, how to administer injectable or intra-nasal [[glucagon]], and how to use a [[glucose meter]].
...
40 KB (5,542 words) - 21:49, 14 March 2024
...allow it to dissolve under the tongue, also referred to as ''[[sublingual administration]].'' For example, a hard candy can be dissolved under the tongue, however t
...foods to help the hypoglycemic eat, how to administer injectable or intra-nasal [[glucagon]], and how to use a [[glucose meter]].
...
37 KB (5,139 words) - 21:45, 14 March 2024
...ages=1–3}}</ref> However, when a medication is administered via [[route of administration|routes]] other than intravenous, its bioavailability is generally{{cref|TH}
For [[dietary supplements]], herbs and other nutrients in which the route of administration is nearly always oral, bioavailability generally designates simply the quan
...
25 KB (3,394 words) - 17:46, 3 January 2023
...allow it to dissolve under the tongue, also referred to as ''[[sublingual administration]].'' For example, a hard candy can be dissolved under the tongue, however t
...foods to help the hypoglycemic eat, how to administer injectable or intra-nasal [[glucagon]], and how to use a [[glucose meter]].
...
37 KB (5,277 words) - 21:44, 14 March 2024
...eased [[hemoglobin]] levels, [[renal impairment]], [[pharyngitis]], and/or nasal congestion. A 2014 Cochrane systematic review based on randomized controlle
...further investigation." A later meta-analysis by the U.S. [[Food and Drug Administration]] (FDA) of 31 randomized controlled trials comparing ARBs to other treatmen
...
19 KB (2,554 words) - 18:03, 25 March 2024
...apy/ja|細胞治療]]（[[stem cell/ja|幹細胞]]治療など）を含むバイオ医薬品の区別である。その他、作用機序、[[route of administration|投与経路]]、影響を受ける[[biological system/ja|生物学的システム]]、[[therapeutic effect/ja|治療効果
医薬品または薬物は、[[chemical property/ja|化学的性質]]、投与方法または[[route of administration/ja|投与経路]]、影響を受ける[[biological system/ja|生物学的系]]、または[[therapeutic effect/ja|治
...
58 KB (1,845 words) - 17:09, 5 November 2023
...eased [[hemoglobin]] levels, [[renal impairment]], [[pharyngitis]], and/or nasal congestion. A 2014 Cochrane systematic review based on randomized controlle
...further investigation." A later meta-analysis by the U.S. [[Food and Drug Administration]] (FDA) of 31 randomized controlled trials comparing ARBs to other treatmen
...
20 KB (2,701 words) - 21:51, 21 April 2024
| routes_of_administration = [[By mouth]], [[intramuscular]], [[nasal spray]]
...l cancer]]. It is used by mouth, by [[injection into a muscle]], or as a [[nasal spray]].
...
15 KB (2,091 words) - 22:09, 6 April 2024
...via a [[dermal patch|patch]] on the skin, [[suppository]], or [[sublingual administration|dissolution under the tongue]].
...eneric Drugs", Center for Drug Evaluation and Research, U.S. Food and Drug Administration|website=Fda.gov|access-date=11 October 2017|url-status=live|archive-url=htt
...
31 KB (4,168 words) - 09:37, 7 January 2023
| routes_of_administration = [[By mouth]], [[intramuscular]], [[nasal spray]]
...l cancer]]. It is used by mouth, by [[injection into a muscle]], or as a [[nasal spray]].
...
16 KB (2,161 words) - 22:09, 6 April 2024
...assify medicines are by mode of action, [[route of administration|route of administration]], [[biological system|biological system]] affected, or [[therapeutic effec
...property|chemical properties]], mode or [[route of administration|route of administration]], [[biological system|biological system]] affected, or [[therapeutic effec
...
52 KB (6,923 words) - 17:09, 5 November 2023